Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Oncology Research|October 6, 2025
Predictive Value of Serum VEGF Levels in Non-Small Cell Lung Cancer: A ReviewEleni Kokkotou, Andriani Charpidou, Nikolaos SyrigosCancers|February 11, 2023
Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment OptionsGeorgia Gomatou, Nikolaos Syrigos, Elias KotteasCancer Diagnosis & Prognosis|July 11, 2022
The Role of Decoy Receptor DcR3 in Gastrointestinal MalignancyStyliani Lagou, Dimitra Grapsa, Nikolaos Syrigos, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 28, 2025
Inflammation markers in lung cancer: prognostic and predictive valuePaschalina Tsopa, Nikolaos Syrigos, Christos Kosmas, et al.International Journal of Dermatology|February 6, 2018
Treatment response to omalizumab in patients with refractory chronic spontaneous urticariaNikolaos Syrigos, Dimitra Grapsa, Maria Zande, et al.International Journal of Molecular Sciences|June 2, 2021
Programmed Death-Ligand 1 as a Regulator of Tumor Progression and MetastasisIoannis A Vathiotis, Georgia Gomatou, Dimitrios J Stravopodis, et al.International Journal of Molecular Sciences|June 2, 2021
Tumor Dormancy: Implications for Invasion and MetastasisGeorgia Gomatou, Nikolaos Syrigos, Ioannis A Vathiotis, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 22, 2024
Mechanisms of primary resistance to immune checkpoint inhibitors in NSCLCGeorgia Gomatou, Andriani Charpidou, Peifeng Li, et al.Anticancer Research|January 25, 2023
Breaking Bad News During the COVID-19 Pandemic: A Systematic Review of the LiteratureGeorgios Goumas, Nikolaos Syrigos, Eleni Fyta, et al.Journal of Personalized Medicine|August 29, 2024
Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not GoldGeorgios Goumas, Theodoros I Dardavesis, Konstantinos Syrigos, et al.Pageof 5